The reduced incidence of ECG-LVH with trandolapril was not explained by the small differences in blood pressure control between the two treatment groups, because risk reduction was highly significant even after adjustments were made for blood pressure control achieved on follow-up and for blood pressure reductions observed versus baseline.
← all excerpts
Preventing left ventricular hypertrophy by ACE inhibition in hypertensive patients with type 2 diabetes: a prespecified analysis of the Bergamo Nephrologic Diabetes Complications Trial (BENEDICT).
1
—
—